RxGen
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Science Park, New Haven, Connecticut, ...Phone Number
(203) 498-9706Website
www.rx-gen.comRevenue
$16.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RxGen
Virscio is a team of experienced scientists and innovators dedicated to addressing significant human health challenges through biomedical research. They offer a range of services including contract research, preclinical services, and collaborative research, aimed at reducing the time, cost, and risk of translating concepts to clinical success. Their focus is on delivering definitive, actionable data from human-relevant test systems while continually innovating to support therapeutic advances. Virscio's intended clients include organizations and researchers in the biomedical field seeking effective solutions for health challenges.Explore more
RxGen Org Chart
MM
Research Scientist
ZG
Science Research Specialist
MO
Research Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RxGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if RxGen is spiking on competitors!
Product Launch: Get notified when RxGen launches new products
Congratulate Masked Content for being promoted to Masked Content at RxGen
Funding: Get notified immidiatlly once RxGen has new funding data
Click to see if RxGen had a recent Job posting/layoffs
RxGen, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on RxGen recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if RxGen has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to RxGen
Compare insights from companies similar to RxGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RxGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RxGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RxGen.
RxGen News & Media
RxGen to Deliver Multiple Presentations at Association for Research in Vision and Ophthalmology Annual Meeting
NEW HAVEN, Conn., April 22, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, today announced that the company will be presenting at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO) in Vancouver, Canada from April 28 to May 2, 2019. RxGen will present five posters describing the development of new disease models and methods of efficacy characterization for multiple ophthalmologic indications for which standard translational modeling has b
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RxGen
Sign Up For FreeTo access detailed company insights
Virscio is a team of experienced scientists and innovators dedicated to addressing significant human health challenges through biomedical research. They offer a range of services including contract research, preclinical services, and collaborative research, aimed at reducing the time, cost, and risk of translating concepts to clinical success. Thei... Read More
